Last updated on November 2016

Multicenter Post-marketing Non-interventional Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)

Brief description of study

This non-interventional study will observe the usage and efficacy of RoActemra/Actemra in patients with rheumatoid arthritis (RA) who have recently begun treatment. The treatment regimen will be directed by the treating physician according to clinical practice. Patients are expected to be observed for approximately 6 months after beginning treatment.

Clinical Study Identifier: NCT02101307

Find a site near you

Start Over